PTCT

#1185
PTC Therapeutics, Inc.
73.01 USD
+3.68%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
73.01
73.01
년간 변동
35.95
87.50
일일 변동
+3.68%
월간 변동
+12.70%
6달 변화
+10.91%
년간 변동율
+63.01%
이전 종가
70.42
Open
73.01
Bid
Ask
Low
73.01
High
73.01
양
222
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 6.04 B
  • Employee 991
  • Founded 1998
  • CEO Matthew B. Klein
  • Website www.ptcbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000QT15P7
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.76
Price to sales ratio
3.88

PTC Therapeutics Inc

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

뉴스